Literature DB >> 22499361

Dermal absorption of finite doses of volatile compounds.

H Frederick Frasch1.   

Abstract

Laplace domain solutions to a previously published finite dose skin diffusion model are presented. The purpose of the current analysis is to derive a simple algebraic expression quantifying the total mass that is systemically absorbed at infinite time after exposure, relative to the applied mass. The resulting expression is a function of two dimensionless parameters: f, the fractional depth within the skin surface through which the permeant is initially deposited, and χ, the ratio of maximum evaporation flux to maximum dermal flux. The result may be useful for dermal risk assessment as well as in the evaluation of cosmetic and pharmaceutical product performance.
Copyright © 2012 Wiley Periodicals, Inc.

Mesh:

Year:  2012        PMID: 22499361      PMCID: PMC4664054          DOI: 10.1002/jps.23149

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

1.  Kinetics of finite dose absorption through skin 2: volatile compounds.

Authors:  Gerald B Kasting; Matthew A Miller
Journal:  J Pharm Sci       Date:  2006-02       Impact factor: 3.534

  1 in total
  3 in total

1.  In vitro human skin permeation of benzene in gasoline: Effects of concentration, multiple dosing and skin preparation.

Authors:  H Frederick Frasch; Ana M Barbero
Journal:  J Expo Sci Environ Epidemiol       Date:  2017-08-09       Impact factor: 5.563

2.  The transient dermal exposure II: post-exposure absorption and evaporation of volatile compounds.

Authors:  H Frederick Frasch; Annette L Bunge
Journal:  J Pharm Sci       Date:  2015-01-21       Impact factor: 3.534

3.  Analysis of finite dose dermal absorption data: implications for dermal exposure assessment.

Authors:  H Frederick Frasch; G Scott Dotson; Annette L Bunge; Chen-Peng Chen; John W Cherrie; Gerald B Kasting; John C Kissel; Jennifer Sahmel; Sean Semple; Simon Wilkinson
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-05-29       Impact factor: 5.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.